Loading company…
Riskpilot
← Back to search
Sign in
Get full access
GYNOVA AS
AS
Active
Org 920772706
Dybwads gate 2, 0367 Oslo
Medical specialists activities · NACE 8622
Est. 2018
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 4,7M
+10% vs 2023
EBITDA margin
29.9%
+340% vs 2023
Equity ratio
61.5%
Financial strength
Net profit 2024
NOK 1,1M
+306% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2020
1M
0%
2021
1M
0%
2022
0M
-100%
2023
1M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 4,7M
+10%
EBITDA
NOK 1,4M
+340%
Net profit
NOK 1,1M
+306%
Total assets
NOK 2,5M
+52%
Equity
NOK 1,5M
+214%
Employees
1
—
Company information
Legal name
GYNOVA AS
Org number
920772706
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
25. april 2018
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drift av gynokologisk virksomhet, konsulentvirksomhet samt det som naturlig står i forbindelse med dette.
Contact
Address
Dybwads gate 2, 0367 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
1M
3M
4M
6M
4M
2020
4M
2021
4M
2022
4M
2023
5M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
0M
2023
1M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
3 865
3 986
4 006
4 278
4 686
Staff expenses
−1 684
−1 668
−1 733
−2 229
−1 466
EBITDA
626
763
724
318
1 400
Depreciation & amort.
−593
−593
−593
−23
−45
EBIT
33
169
130
295
1 355
Net financials
−17
−13
−9
−21
−52
Profit before tax
16
156
121
274
1 303
Tax
50
100
104
14
249
Net profit
−34
57
17
260
1 054
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 901
2 100
1 448
1 636
2 490
Equity
173
230
234
487
1 531
Long-term debt
0
684
642
653
435
Short-term debt
2 728
1 186
571
496
523
Total debt
2 728
1 870
1 214
1 149
958
Financial ratios
5-year trend
EBITDA margin
29.9%
This company
15.8%
Market median
+89% vs market
2020
2024
Equity ratio
61.5%
This company
38.2%
Market median
+61% vs market
2020
2024
Return on equity
68.8%
This company
18.4%
Market median
+274% vs market
2020
2024
Net profit margin
22.5%
This company
8.1%
Market median
+178% vs market
2020
2024
Asset turnover
1.88×
This company
1.12×
Market median
+68% vs market
2020
2024
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
AV
Anna Victoria Høeg Wohlfahrt
Chairman
2018
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Vhw Holding As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Vhw Holding As
GYNOVA AS
(this company)
Board network connections
Board members of GYNOVA AS also hold positions in
0
other companies.
Person
Role here
Other companies
Anna Victoria Høeg Wohlfahrt
Chairman
0 companies